CACI director reports 338 RSUs grant, vesting on 2026 dates
CACI International (CACI) reported an insider equity award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CACI International (CACI) reported an insider equity award. Director Debora A. Plunkett filed a Form 4 showing an acquisition of 338 Restricted Stock Units (RSUs) on October 16, 2025. The RSUs are scheduled to vest as follows: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Following the reported transaction, the filing lists 338 derivative securities beneficially owned with direct (D) ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 338 | $0.00 | $0.00 |
Footnotes (1)
- F1. On October 16, 2025, Ms. Plunkett was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CACI (CACI) disclose in this Form 4?
How many RSUs were granted to the CACI director?
What is the vesting schedule for the 338 CACI RSUs?
What is the ownership form after the CACI RSU grant?
How many derivative securities are beneficially owned after the transaction?
Who is the reporting person in the CACI Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.